← Evidence map

ArticleMolecular cancer therapeutics2016

Development of a RSK Inhibitor as a Novel Therapy for Triple-Negative Breast Cancer.

Katarzyna A Ludwik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

36 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 27528706